Available Brands
Did you find this information helpful?
Author Details

Written By
Naina Boruah
MSc Biomedical Science

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 29 Oct 2026 | 05:01 AM (IST)

Want to know more?
Read Our Editorial Policy
Quick Summary
KETOANALOGUE,ESSENTIAL AMINO ACIDS
Last updated on 29 Oct 2026 | 05:01 AM (IST)
KETOANALOGUE,ESSENTIAL AMINO ACIDS
Molecule Overview
This refers to the same class of renal-specific nutrition therapy as alpha-ketoanalogue products (most commonly known as Ketosteril), which combine nitrogen-free ketoanalogues of certain essential amino acids with a small number of standard essential amino acids, formulated specifically to support patients with chronic kidney disease (CKD) who are following a low-protein diet. It is a prescription/dietitian-guided product used specifically in pre-dialysis CKD care.
Medical Classification
Therapeutic Class: Medical nutrition therapy for chronic kidney disease (renal-specific ketoacid/amino acid supplement).
Pharmacological Class: Combination of ketoanalogues of essential amino acids (nitrogen-free) and standard essential amino acids.
Drug Family: Renal ketoacid/amino acid supplement therapies.
ATC Classification: V06DD (Amino acids, including combinations with polypeptides) — specific coding varies by product and region.
Conditions Treated
Approved/established use: Adjunct nutritional management of chronic kidney disease (typically CKD stages 3b-5, pre-dialysis), used alongside a low or very low protein diet to help meet essential amino acid needs while reducing nitrogen waste burden.
Commonly used for: Metabolically stable adults with advanced CKD who are following a structured low-protein dietary plan under nephrology and dietitian supervision.
Off-label use (only under medical guidance): Not typically used off-label; use is specific to structured CKD nutritional management.
Available Strengths & Dosage Forms
Oral tablets: coated tablets containing a fixed blend of ketoanalogues (of isoleucine, leucine, phenylalanine, valine, methionine) as calcium salts, along with the standard essential amino acids lysine, threonine, tryptophan, histidine, and tyrosine.
How the Molecule Works
This combination supplies some essential amino acids in their nitrogen-free "ketoanalogue" form, which the body converts into the active amino acid using recycled nitrogen rather than adding new nitrogen waste, alongside a smaller number of essential amino acids that don't have a practical or effective ketoanalogue form and are included directly. Together, this blend allows patients on a low-protein diet to meet their full essential amino acid requirements while minimising the nitrogen burden on already-impaired kidneys.
Dosage & Administration
Standard dose: Approximately 1 tablet per 5 kg body weight per day, taken alongside a very low protein diet (0.3-0.4 g/kg/day), divided across meals, as directed by a nephrologist and renal dietitian.
Condition-wise dose: Dose and specific dietary protein target are individualised based on CKD stage, nutritional status, and the patient's ability to adhere to the dietary plan.
Route: Oral, taken with meals.
Missed dose: Take with the next meal as close to the regular schedule as possible; don't double up.
Overdose: Excessive intake could theoretically raise blood calcium levels, given the calcium-salt formulation of the ketoanalogue components; requires medical guidance if significantly exceeded.
Side Effects
Common: Generally well tolerated; mild gastrointestinal discomfort can occasionally occur.
Serious: Hypercalcemia (excess blood calcium), a theoretical risk given the calcium-salt formulation, particularly if combined with other calcium or vitamin D supplementation without monitoring.
Emergency symptoms: Signs of hypercalcemia (nausea, confusion, excessive thirst) should prompt medical review.
Recovery advice: This therapy is used under close nephrology and dietitian supervision, which allows early identification of any tolerability or calcium-related issues.
Warnings & Precautions
Pregnancy: Used only under specialist guidance, as very low protein diets in pregnancy require careful individualised management.
Breastfeeding: Used only under specialist guidance.
Liver disease: Used with caution and specialist guidance, given amino acid metabolism considerations.
Kidney disease: This is the core condition being managed; use is specifically tailored to CKD stage and nutritional status.
Elderly: Used under specialist guidance; nutritional adequacy and adherence are particularly important to assess in this age group.
Children: Used under specialist pediatric nephrology guidance if needed, with individualised dosing.
Drug Interactions
Calcium and vitamin D supplements: combined use requires monitoring of blood calcium levels, given the calcium-salt basis of the ketoanalogue components.
Phosphate binders and other CKD-specific medicines: used as part of an overall CKD management plan, coordinated by the treating nephrologist.
No major systemic drug-metabolism interactions have been identified, as this is a nutritional amino acid/ketoacid therapy rather than a drug metabolised through major liver enzyme pathways.
Monitoring Requirements
Kidney function tests (eGFR, creatinine) periodically to assess disease progression.
Serum albumin and nutritional status assessment.
Serum calcium and phosphate levels periodically.
Dietitian follow-up to support adherence to the prescribed low-protein dietary pattern.
Alternative Molecules
Alpha-ketoanalogue-only products, standard essential amino acid supplements without ketoanalogue modification, standard low-protein diet without supplementation, alternative approaches depending on CKD stage and nutritional needs.
Combination Therapies
Used specifically alongside a prescribed low or very low protein diet as part of a structured CKD nutritional management plan; combined with other standard CKD medical therapies as part of overall nephrology care.
Chronic Kidney Disease Nutritional Management
Renal Diet Supportive Therapies
Pre-Dialysis CKD Care
FAQs
Q1.
It's used alongside a low or very low protein diet to help patients with chronic kidney disease meet their essential amino acid needs while minimising nitrogen waste.
Q2.
This formulation includes both ketoanalogue forms of certain amino acids and standard forms of other essential amino acids that don't have a practical ketoanalogue equivalent, providing a more complete amino acid profile.
Q3.
Dosing is generally based on body weight, commonly around 1 tablet per 5 kg body weight per day, divided across meals.
Q4.
No, it's a nutritional adjunct used alongside standard CKD management, not a replacement for other kidney-specific medicines.
Q5.
Because it's used with significant dietary protein restriction, regular monitoring of kidney function, nutritional status, and blood calcium helps ensure the approach remains safe and effective.
References
Disclaimer
The information on this page is for educational purposes only and is not a substitute for medical advice. Please consult your doctor to know if this treatment is appropriate for your condition.






